Search Within

Filemon Dela Cruz

Formats
  1. Meeting Abstract (31)
  2. Journal Article (28)
  3. Editorial (2)
  4. Review (1)
Groups
  1. Pediatrics, Department of (62)
  2. Sarcoma Service (Pediatrics) (62)
  3. Center for Hematologic Malignancies (45)
  4. Tow Center for Developmental Oncology (TCDO) (43)
  5. Executive Committee, Center for Hematologic Malignancies (41)
  6. Stem Cell Transplantation and Cellular Therapy Service (41)

More Groups

People
  1. Andrew Kung (41)
  2. Daoqi You (16)
  3. Julia Glade Bender (16)
  4. Michael Ortiz (14)
  5. Emily Slotkin (13)
  6. Glorymar Ibanez Sanchez (12)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (10)
  3. Pediatric Blood and Cancer (8)
  4. Cancer Discovery (3)
  5. Nature Communications (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (12)
  3. Wiley Periodicals, Inc (8)
  4. Nature Publishing Group (7)
  5. Elsevier Inc. (3)
  6. Nature Research (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results of the phase 2 cohort of lenvatinib (LEN) plus everolimus (EVE) in recurrent/refractory childhood solid tumors, performed in collaboration with the Children's Oncology Group
    Meeting Abstract

    Dela Cruz, F.; Fox, E.; Dubois, S.; Friedman, G.; Croop, J.; Kim, A.; Morgenstern, D.; Balis, F.; Macy, M.; Pressey, J.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Inhibition of ATM kinase by the CNS-penetrant AZD1390 enhanced radiotherapy in neuroblastoma and rhabdomyosarcoma preclinical models
    Meeting Abstract

    Burrow, T.; Graham, K.; Koneru, B.; Farooqi, A.; Houghton, P.; Dela Cruz, F.; Kalapurakal, J.; Reynolds, C. P.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Subclonal somatic copy-number alterations emerge and dominate in recurrent osteosarcoma
    Journal Article

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Arnold, B.; Levine, M. F.; Gundem, G.; Arango Ossa, J. E.; Glodzik, D.; Rodríguez-Sanchez, M. I.; Bouvier, N.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • A transcripto me-based precision oncology platform for patient-therapy alignment in a diverse set of treatment-resistant malignancies
    Journal Article

    Mundi, P. S.; Dela Cruz, F. S.; Grunn, A.; Diolaiti, D.; Mauguen, A.; Rainey, A. R.; Guillan, K.; Siddiquee, A.; You, D.; Realubit, R.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Clonal evolution during metastatic spread in high-risk neuroblastoma
    Journal Article

    Gundem, G.; Levine, M. F.; Roberts, S. S.; Cheung, I. Y.; Medina-Martínez, J. S.; Feng, Y.; Arango-Ossa, J. E.; Chadoutaud, L.; Rita, M.; Asimomitis, G.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A systems biology approach to defining tumor heterogeneity and prognostic and targetable master regulator protein signatures from bulk and single-cell RNAseq in osteosarcoma
    Meeting Abstract

    Tagore, S.; Pavisic, J.; Griffin, A. T.; Janeway, K.; Kung, A. L.; Dela Cruz, F.; Sweet-Cordero, A.; Behroozfard, I.; Leung, S.; Lee, A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting of the nuclear export protein XPO1 represents a non-genetically encoded vulnerability in malignant rhabdoid and Wilms tumors
    Meeting Abstract

    Coutinho, D. F.; Burke, C.; Mundi, P.; Ortiz, M. V.; Vallance, K. L.; Long, M.; Rosales, N.; Ibanez, G.; Marks, L. J.; Diolaiti, D.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Elucidation and pharmacological targeting of master regulator proteins representing mechanistic determinants of breast cancer stem-like tumor initiating cell state
    Meeting Abstract

    Worley, J.; Ding, H.; Noh, H.; Paull, E.; Griffin, A. T.; Grunn, A.; You, D.; Guillan, K.; Bush, E.; Dalerba, P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Case study of single-cell protein activity-based drug prediction and validation for precision treatment of cholangiocarcinoma
    Meeting Abstract

    Tomassoni, L.; Obradovic, A.; Dela Cruz, F.; Yu, D.; Fraser, E.; Bates, S. E.; Saenger, Y.; Califano, A.
    Cancer Research (2022)

    Fulltext@MSK | Save